Abstract
Summary
LPI (LP Information)' newest research report, the “Minimal Invasive Spinal Devices Industry Forecast” looks at past sales and reviews total world Minimal Invasive Spinal Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Minimal Invasive Spinal Devices sales for 2023 through 2029. With Minimal Invasive Spinal Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Minimal Invasive Spinal Devices industry.
This Insight Report provides a comprehensive analysis of the global Minimal Invasive Spinal Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Minimal Invasive Spinal Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Minimal Invasive Spinal Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minimal Invasive Spinal Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minimal Invasive Spinal Devices.
The global Minimal Invasive Spinal Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Minimal Invasive Spinal Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Minimal Invasive Spinal Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Minimal Invasive Spinal Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Minimal Invasive Spinal Devices players cover Bonovo Orthopedics Inc, Camber Spine Technologies LLC, Corelink LLC, CTL Amedica Corp, DePuy Synthes Inc, EIT Emerging Implant Technologies GmbH, H. Lee Moffitt Cancer Center & Research Institute Inc, Inion Oy and Integra LifeSciences Holdings Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Minimal Invasive Spinal Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Endoscope
Fluoroscope
Minimally Invasive Tubular Retractor
Implants
Others
Segmentation by application
Spine Fusion Procedure
Spine Non-fusion Procedure
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bonovo Orthopedics Inc
Camber Spine Technologies LLC
Corelink LLC
CTL Amedica Corp
DePuy Synthes Inc
EIT Emerging Implant Technologies GmbH
H. Lee Moffitt Cancer Center & Research Institute Inc
Inion Oy
Integra LifeSciences Holdings Corp
Maxigen Biotech Inc
MicroPort Scientific Corp
OrthoPediatrics Corp
Osseus Fusion Systems LLC
OxSonics Ltd
Safe Orthopaedics SA
SeaSpine Inc.
Sheba Medical Center
Solco Biomedical Co Ltd
Spinal Balance Inc.
Stryker Corp
Vivonics Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Minimal Invasive Spinal Devices market?
What factors are driving Minimal Invasive Spinal Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Minimal Invasive Spinal Devices market opportunities vary by end market size?
How does Minimal Invasive Spinal Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Minimal Invasive Spinal Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Minimal Invasive Spinal Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Minimal Invasive Spinal Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minimal Invasive Spinal Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minimal Invasive Spinal Devices.
The global Minimal Invasive Spinal Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Minimal Invasive Spinal Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Minimal Invasive Spinal Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Minimal Invasive Spinal Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Minimal Invasive Spinal Devices players cover Bonovo Orthopedics Inc, Camber Spine Technologies LLC, Corelink LLC, CTL Amedica Corp, DePuy Synthes Inc, EIT Emerging Implant Technologies GmbH, H. Lee Moffitt Cancer Center & Research Institute Inc, Inion Oy and Integra LifeSciences Holdings Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Minimal Invasive Spinal Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Endoscope
Fluoroscope
Minimally Invasive Tubular Retractor
Implants
Others
Segmentation by application
Spine Fusion Procedure
Spine Non-fusion Procedure
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bonovo Orthopedics Inc
Camber Spine Technologies LLC
Corelink LLC
CTL Amedica Corp
DePuy Synthes Inc
EIT Emerging Implant Technologies GmbH
H. Lee Moffitt Cancer Center & Research Institute Inc
Inion Oy
Integra LifeSciences Holdings Corp
Maxigen Biotech Inc
MicroPort Scientific Corp
OrthoPediatrics Corp
Osseus Fusion Systems LLC
OxSonics Ltd
Safe Orthopaedics SA
SeaSpine Inc.
Sheba Medical Center
Solco Biomedical Co Ltd
Spinal Balance Inc.
Stryker Corp
Vivonics Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Minimal Invasive Spinal Devices market?
What factors are driving Minimal Invasive Spinal Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Minimal Invasive Spinal Devices market opportunities vary by end market size?
How does Minimal Invasive Spinal Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Minimal Invasive Spinal Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Minimal Invasive Spinal Devices by Country/Region, 2018, 2022 & 2029
2.2 Minimal Invasive Spinal Devices Segment by Type
2.2.1 Endoscope
2.2.2 Fluoroscope
2.2.3 Minimally Invasive Tubular Retractor
2.2.4 Implants
2.2.5 Others
2.3 Minimal Invasive Spinal Devices Sales by Type
2.3.1 Global Minimal Invasive Spinal Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Minimal Invasive Spinal Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Minimal Invasive Spinal Devices Sale Price by Type (2018-2023)
2.4 Minimal Invasive Spinal Devices Segment by Application
2.4.1 Spine Fusion Procedure
2.4.2 Spine Non-fusion Procedure
2.5 Minimal Invasive Spinal Devices Sales by Application
2.5.1 Global Minimal Invasive Spinal Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Minimal Invasive Spinal Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Minimal Invasive Spinal Devices Sale Price by Application (2018-2023)
3 Global Minimal Invasive Spinal Devices by Company
3.1 Global Minimal Invasive Spinal Devices Breakdown Data by Company
3.1.1 Global Minimal Invasive Spinal Devices Annual Sales by Company (2018-2023)
3.1.2 Global Minimal Invasive Spinal Devices Sales Market Share by Company (2018-2023)
3.2 Global Minimal Invasive Spinal Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Minimal Invasive Spinal Devices Revenue by Company (2018-2023)
3.2.2 Global Minimal Invasive Spinal Devices Revenue Market Share by Company (2018-2023)
3.3 Global Minimal Invasive Spinal Devices Sale Price by Company
3.4 Key Manufacturers Minimal Invasive Spinal Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Minimal Invasive Spinal Devices Product Location Distribution
3.4.2 Players Minimal Invasive Spinal Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Minimal Invasive Spinal Devices by Geographic Region
4.1 World Historic Minimal Invasive Spinal Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Minimal Invasive Spinal Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Minimal Invasive Spinal Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Minimal Invasive Spinal Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Minimal Invasive Spinal Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Minimal Invasive Spinal Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Minimal Invasive Spinal Devices Sales Growth
4.4 APAC Minimal Invasive Spinal Devices Sales Growth
4.5 Europe Minimal Invasive Spinal Devices Sales Growth
4.6 Middle East & Africa Minimal Invasive Spinal Devices Sales Growth
5 Americas
5.1 Americas Minimal Invasive Spinal Devices Sales by Country
5.1.1 Americas Minimal Invasive Spinal Devices Sales by Country (2018-2023)
5.1.2 Americas Minimal Invasive Spinal Devices Revenue by Country (2018-2023)
5.2 Americas Minimal Invasive Spinal Devices Sales by Type
5.3 Americas Minimal Invasive Spinal Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Minimal Invasive Spinal Devices Sales by Region
6.1.1 APAC Minimal Invasive Spinal Devices Sales by Region (2018-2023)
6.1.2 APAC Minimal Invasive Spinal Devices Revenue by Region (2018-2023)
6.2 APAC Minimal Invasive Spinal Devices Sales by Type
6.3 APAC Minimal Invasive Spinal Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Minimal Invasive Spinal Devices by Country
7.1.1 Europe Minimal Invasive Spinal Devices Sales by Country (2018-2023)
7.1.2 Europe Minimal Invasive Spinal Devices Revenue by Country (2018-2023)
7.2 Europe Minimal Invasive Spinal Devices Sales by Type
7.3 Europe Minimal Invasive Spinal Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Minimal Invasive Spinal Devices by Country
8.1.1 Middle East & Africa Minimal Invasive Spinal Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Minimal Invasive Spinal Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Minimal Invasive Spinal Devices Sales by Type
8.3 Middle East & Africa Minimal Invasive Spinal Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Minimal Invasive Spinal Devices
10.3 Manufacturing Process Analysis of Minimal Invasive Spinal Devices
10.4 Industry Chain Structure of Minimal Invasive Spinal Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Minimal Invasive Spinal Devices Distributors
11.3 Minimal Invasive Spinal Devices Customer
12 World Forecast Review for Minimal Invasive Spinal Devices by Geographic Region
12.1 Global Minimal Invasive Spinal Devices Market Size Forecast by Region
12.1.1 Global Minimal Invasive Spinal Devices Forecast by Region (2024-2029)
12.1.2 Global Minimal Invasive Spinal Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Minimal Invasive Spinal Devices Forecast by Type
12.7 Global Minimal Invasive Spinal Devices Forecast by Application
13 Key Players Analysis
13.1 Bonovo Orthopedics Inc
13.1.1 Bonovo Orthopedics Inc Company Information
13.1.2 Bonovo Orthopedics Inc Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.1.3 Bonovo Orthopedics Inc Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bonovo Orthopedics Inc Main Business Overview
13.1.5 Bonovo Orthopedics Inc Latest Developments
13.2 Camber Spine Technologies LLC
13.2.1 Camber Spine Technologies LLC Company Information
13.2.2 Camber Spine Technologies LLC Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.2.3 Camber Spine Technologies LLC Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Camber Spine Technologies LLC Main Business Overview
13.2.5 Camber Spine Technologies LLC Latest Developments
13.3 Corelink LLC
13.3.1 Corelink LLC Company Information
13.3.2 Corelink LLC Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.3.3 Corelink LLC Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Corelink LLC Main Business Overview
13.3.5 Corelink LLC Latest Developments
13.4 CTL Amedica Corp
13.4.1 CTL Amedica Corp Company Information
13.4.2 CTL Amedica Corp Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.4.3 CTL Amedica Corp Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CTL Amedica Corp Main Business Overview
13.4.5 CTL Amedica Corp Latest Developments
13.5 DePuy Synthes Inc
13.5.1 DePuy Synthes Inc Company Information
13.5.2 DePuy Synthes Inc Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.5.3 DePuy Synthes Inc Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 DePuy Synthes Inc Main Business Overview
13.5.5 DePuy Synthes Inc Latest Developments
13.6 EIT Emerging Implant Technologies GmbH
13.6.1 EIT Emerging Implant Technologies GmbH Company Information
13.6.2 EIT Emerging Implant Technologies GmbH Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.6.3 EIT Emerging Implant Technologies GmbH Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 EIT Emerging Implant Technologies GmbH Main Business Overview
13.6.5 EIT Emerging Implant Technologies GmbH Latest Developments
13.7 H. Lee Moffitt Cancer Center & Research Institute Inc
13.7.1 H. Lee Moffitt Cancer Center & Research Institute Inc Company Information
13.7.2 H. Lee Moffitt Cancer Center & Research Institute Inc Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.7.3 H. Lee Moffitt Cancer Center & Research Institute Inc Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 H. Lee Moffitt Cancer Center & Research Institute Inc Main Business Overview
13.7.5 H. Lee Moffitt Cancer Center & Research Institute Inc Latest Developments
13.8 Inion Oy
13.8.1 Inion Oy Company Information
13.8.2 Inion Oy Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.8.3 Inion Oy Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Inion Oy Main Business Overview
13.8.5 Inion Oy Latest Developments
13.9 Integra LifeSciences Holdings Corp
13.9.1 Integra LifeSciences Holdings Corp Company Information
13.9.2 Integra LifeSciences Holdings Corp Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.9.3 Integra LifeSciences Holdings Corp Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Integra LifeSciences Holdings Corp Main Business Overview
13.9.5 Integra LifeSciences Holdings Corp Latest Developments
13.10 Maxigen Biotech Inc
13.10.1 Maxigen Biotech Inc Company Information
13.10.2 Maxigen Biotech Inc Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.10.3 Maxigen Biotech Inc Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Maxigen Biotech Inc Main Business Overview
13.10.5 Maxigen Biotech Inc Latest Developments
13.11 MicroPort Scientific Corp
13.11.1 MicroPort Scientific Corp Company Information
13.11.2 MicroPort Scientific Corp Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.11.3 MicroPort Scientific Corp Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MicroPort Scientific Corp Main Business Overview
13.11.5 MicroPort Scientific Corp Latest Developments
13.12 OrthoPediatrics Corp
13.12.1 OrthoPediatrics Corp Company Information
13.12.2 OrthoPediatrics Corp Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.12.3 OrthoPediatrics Corp Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 OrthoPediatrics Corp Main Business Overview
13.12.5 OrthoPediatrics Corp Latest Developments
13.13 Osseus Fusion Systems LLC
13.13.1 Osseus Fusion Systems LLC Company Information
13.13.2 Osseus Fusion Systems LLC Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.13.3 Osseus Fusion Systems LLC Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Osseus Fusion Systems LLC Main Business Overview
13.13.5 Osseus Fusion Systems LLC Latest Developments
13.14 OxSonics Ltd
13.14.1 OxSonics Ltd Company Information
13.14.2 OxSonics Ltd Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.14.3 OxSonics Ltd Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 OxSonics Ltd Main Business Overview
13.14.5 OxSonics Ltd Latest Developments
13.15 Safe Orthopaedics SA
13.15.1 Safe Orthopaedics SA Company Information
13.15.2 Safe Orthopaedics SA Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.15.3 Safe Orthopaedics SA Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Safe Orthopaedics SA Main Business Overview
13.15.5 Safe Orthopaedics SA Latest Developments
13.16 SeaSpine Inc.
13.16.1 SeaSpine Inc. Company Information
13.16.2 SeaSpine Inc. Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.16.3 SeaSpine Inc. Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 SeaSpine Inc. Main Business Overview
13.16.5 SeaSpine Inc. Latest Developments
13.17 Sheba Medical Center
13.17.1 Sheba Medical Center Company Information
13.17.2 Sheba Medical Center Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.17.3 Sheba Medical Center Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Sheba Medical Center Main Business Overview
13.17.5 Sheba Medical Center Latest Developments
13.18 Solco Biomedical Co Ltd
13.18.1 Solco Biomedical Co Ltd Company Information
13.18.2 Solco Biomedical Co Ltd Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.18.3 Solco Biomedical Co Ltd Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Solco Biomedical Co Ltd Main Business Overview
13.18.5 Solco Biomedical Co Ltd Latest Developments
13.19 Spinal Balance Inc.
13.19.1 Spinal Balance Inc. Company Information
13.19.2 Spinal Balance Inc. Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.19.3 Spinal Balance Inc. Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Spinal Balance Inc. Main Business Overview
13.19.5 Spinal Balance Inc. Latest Developments
13.20 Stryker Corp
13.20.1 Stryker Corp Company Information
13.20.2 Stryker Corp Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.20.3 Stryker Corp Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Stryker Corp Main Business Overview
13.20.5 Stryker Corp Latest Developments
13.21 Vivonics Inc
13.21.1 Vivonics Inc Company Information
13.21.2 Vivonics Inc Minimal Invasive Spinal Devices Product Portfolios and Specifications
13.21.3 Vivonics Inc Minimal Invasive Spinal Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Vivonics Inc Main Business Overview
13.21.5 Vivonics Inc Latest Developments
14 Research Findings and Conclusion